Company: OSRH
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001213900-25-109054
Chunk: 147

Company: OSR Holdings, Inc.
Filing Date: 2025-11-12
Form: 10-Q
Item: Part II, Item 1
Chunk 147
---
 capital position,
and could cause our actual results to differ materially from our historical results or the results contemplated by the forward-looking
statements contained in this report or we could face liquidation. In that event, the trading price of our securities could decline, and
you could lose all or part of your investment. The risks and uncertainties described in our 2024 Annual Report and below are not the only
ones we face. Additional risks and uncertainties that we are unaware of, or that we currently believe are not material, may also become
important factors that adversely affect our business, financial condition and operating results. Except as disclosed below, there have
been no material changes to the risk factors described in Part I, Item 1A, “Risk Factors,” included in our 2024 Annual Report.

Item 2. Unregistered Sales
of Equity Securities and Use of Proceeds

Pursuant to the terms of an Equity Line of Credit
Agreement comprising a Common Stock Purchase Agreement and a Registration Rights Agreement (taken together, the “ELOC Agreement”)
as amended May 6, 2025, the Company may elect, in our sole discretion, to issue and sell to by White Lion Capital LLC dba White Lion GBM
Innovation Fund (“White Lion”), from time to time, up to $78.9 million worth of shares of Common Stock from after the effective
date of a related registration statement until the earlier of December 31, 2026 or the sale of all of such shares to White Lion. Any terms
in initial capitals and not otherwise defined herein shall be as defined in the amended Common Stock Purchase Agreement and/or the Registration
Rights Agreement.

Pursuant to the Common Stock Purchase Agreement,
following the effective date of the resale registration statement registering the shares issuable to White Lion in accordance with the
terms of the Registration Rights Agreement, the Company has the right, but not the obligation, to require White Lion to purchase, from
time to time, up to the lesser of (i) $78,900,000 in aggregate gross purchase price of newly issued shares of Common Stock, par value
$0.0001 per share and (ii) 3,853,467 shares of Common Stock (the “Exchange Cap”), in each case, subject to certain limitations
and conditions set forth in the Common Stock Purchase Agreement.

32

The number of shares of Common Stock that the
Company may require White Lion to purchase in any single sales notice will depend on a number